121 related articles for article (PubMed ID: 7088016)
1. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
Stewart PM; Walser M; Drachman DB
Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
[TBL] [Abstract][Full Text] [Related]
2. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
Warnes DM; Tomas FM; Ballard FJ
Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
[TBL] [Abstract][Full Text] [Related]
3. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
Ballard FJ; Tomas FM; Stern LM
Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
[TBL] [Abstract][Full Text] [Related]
4. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
5. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
Neville HE; Harrold S
Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
[TBL] [Abstract][Full Text] [Related]
6. 3-methylhistidine excretion in myotonic dystrophy.
Griggs RC; Moxley RT; Forbes GB
Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
[TBL] [Abstract][Full Text] [Related]
7. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
McKeran RO; Halliday D; Purkiss P
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
[TBL] [Abstract][Full Text] [Related]
8. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
Corbett AJ
Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M; Carter A; Bacon S; Winearls CG; Smith R
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
[TBL] [Abstract][Full Text] [Related]
10. Effect of prednisone on protein metabolism in Duchenne dystrophy.
Rifai Z; Welle S; Moxley RT; Lorenson M; Griggs RC
Am J Physiol; 1995 Jan; 268(1 Pt 1):E67-74. PubMed ID: 7840185
[TBL] [Abstract][Full Text] [Related]
11. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
Pizarro M; Lissi E; Reyes J; Holmgren J
Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
[TBL] [Abstract][Full Text] [Related]
12. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment.
Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S
J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992
[TBL] [Abstract][Full Text] [Related]
13. Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion.
Franciotta D; Zanardi MC; Albertotti L; Orcesi S; Berardinelli A; Pichiecchio A; Uggetti C; Tagliabue A
Acta Diabetol; 2003 Oct; 40 Suppl 1():S290-2. PubMed ID: 14618496
[TBL] [Abstract][Full Text] [Related]
14. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
Rudman D; Kutner MH; Chawla RK; Goldsmith MA
J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
[TBL] [Abstract][Full Text] [Related]
15. Proteins of muscle subcellular fractions in Duchenne progressive muscular dystrophy stained with "stains-all" cationic carbocyanine dye and with Coomassie Blue.
Niebroj-Dobosz I; Kornguth S; Schutta H; Siegel FL; Hausmanowa-Petrusewicz I
Muscle Nerve; 1989 Apr; 12(4):273-80. PubMed ID: 2770780
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
17. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
Rennie MJ; Millward DJ
Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
[No Abstract] [Full Text] [Related]
18. [The mechanism of muscle fiber breakdown in Duchenne muscular dystrophy--with particular reference to the significance of opaque muscle fibers].
Uchino M; Araki S; Yoshida O
Rinsho Shinkeigaku; 1985 Aug; 25(8):944-8. PubMed ID: 4064436
[No Abstract] [Full Text] [Related]
19. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
László A; Klujber L
Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
